Study of biocompatibility, cytotoxic activity in vitro of a tetrazole-containing derivative of 2-amino-4,6-di(aziridin-1-yl)-1,3,5-triazine-Reference-Cited by-同舟云学术

Study of biocompatibility, cytotoxic activity in vitro of a tetrazole-containing derivative of 2-amino-4,6-di(aziridin-1-yl)-1,3,5-triazine

Published:2022-11 Issue: Volume:629 Page:176-182
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Mikolaichuk Olga V.,Popova Elena А.,Protas Alexandra V.,Shemchuk Olga S.,Vasina Lubov V.,Pavlyukova Yulia N.,Potanin Artem A.,Molchanov Oleg Е.^ORCID,Maistrenko Dmitrii N.,Semenov Konstantin N.^ORCID,Sharoyko Vladimir V.

Funder

Ministry of Health of the Russian Federation

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference23 articles.

1. What is cancer chemotherapy?;Nygren;Acta Oncol,2001

2. From chemotherapy to biological therapy: a review of novel concepts to reduce the side effects of systemic cancer treatment;Schirrmacher;Int. J. Oncol.,2019

3. From old alkylating agents to new minor groove binders;Puyo;Crit. Rev. Oncol.-Hematol.,2014

4. Heterocyclic scaffolds as promising anticancer agents against tumours of the central nervous system: exploring the scope of indole and carbazole derivatives;Sherer;Eur. J. Med. Chem.,2015

5. Deciphering the key heterocyclic scaffolds in targeting microtubules, kinases and carbonic anhydrases for cancer drug development;Peerzada;Pharmacol. Ther.,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atranorin is a novel potential candidate drug for treating myelodysplastic syndrome;Journal of Molecular Liquids;2024-11

2. Modification of fullerene with amino acids as a method for obtaining biocompatible materials with a protective effect;Fullerenes, Nanotubes and Carbon Nanostructures;2024-04-09

3. Atranorin is a novel potential candidate drug for treating myelodysplastic syndrome;2024-04-05

4. Synthesis, characterization and biocompatibility of glycine modified graphene oxide;Fullerenes, Nanotubes and Carbon Nanostructures;2023-11-10

5. Non-covalent conjugate based on graphene oxide and a cytotoxic agent containing 1,3,5-triazine derivative and (5-phenyl-2H-tetrazol-2-yl)acetoxy moiety: Synthesis, characterization, properties and cytotoxic activity;Mendeleev Communications;2023-11